Home | Volume 10

CDK inhibitors in 3D: Problems with the drugs, their development plans or their linkage to disease?

Dr. Andrew Hughes et. al.

Download as PDF : 05. Hughes, 41-54.pdf : 162285 bytes


Previous Article: Naturally occurring translational models for development of cancer gene therapy
Next Article: Antioxidative gene therapy using superoxide dismutase in ischemia-reperfusion injury of testes in rats
The Publication:
CDK inhibitors in 3D: Problems with the drugs, their development plans or their linkage to disease?
is not formatted in HTML just yet, but will be available very soon!
Please view as a PDF: 05. Hughes, 41-54.pdf in the meantime.